Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution Breastfeeding
For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution and its risk associated with lactation. We will also discuss the usage of Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution and some common side effects associated with Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution.

What is Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution ?


GEMZAR® is a nucleoside metabolic inhibitor indicated: in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. (1.1) in combination with paclitaxel, for first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. (1.2) in combination with cisplatin, for the treatment of non-small cell lung cancer. (1.3) as a single agent for the treatment of pancreatic cancer. (1.4) 1.1 Ovarian Cancer GEMZAR® in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. 1.2 Breast Cancer GEMZAR in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. 1.3 Non-Small Cell Lung Cancer GEMZAR in combination with cisplatin is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC). 1.4 Pancreatic Cancer GEMZAR is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. GEMZAR is indicated for patients previously treated with fluorouracil.

Can I use Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution while breastfeeding?

Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution dangerous while breastfeeding
Our analysis of Gemcitabine which are active ingredients in Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution indicates that Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution is dangerous to use in breastfeeding. We strongly recommend you to go through detailed analysis of Gemcitabine as below and do not use Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution during breastfeeding.

Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution Breastfeeding Analsys


Gemcitabine while Breastfeeding

Dangerous

CAS Number: 95058-81-4

Drug is cleared from the body in 16 elimination half-lives. Resuming breastfeeding is likely safe after 7 days of of pumping-and-dumping.

Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution Breastfeeding Analsys - 2


Gemcitabine while Breastfeeding

CAS Number: 95058-81-4

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent gemcitabine therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]

Is Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution safe while breastfeeding

What should I do if I am breastfeeding mother and I am already exposed to Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution?

You should immediately inform your health care provider about Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution usage and your breastfeeding interval after usage of . If you feel baby is having abnormal behavior or any other health issue please call 911 immediately or contact nearest medical emergency center.


My doctor has prescribed me Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution, what should I do?

Please double check with your doctor if he is aware of your breastfeeding stratus, Ask your doctor if there is any safe alternative of Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution. Check with your doctor if you shall temporally stop breastfeeding. You may go for second opinion as well. Still after all of this if your doctor still recommends Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution then go for it as they have access on more detailed medical and scientific information and they understand your individual medical situation much better.


If I am using Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution, will my baby need extra monitoring?

Extreme level of monitoring required as Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution could be dangerous for kid.


Who can I talk to if I have questions about usage of Gemzar | Gemcitabine Hydrochloride Injection, Powder, Lyophilized, For Solution in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week